OPKO Health, Inc. – FDA EIR, Mar 1, 2021

Record Details

This EIR record concerns OPKO Health, Inc., with an inspection on March 1, 2021, issued by the Florida District Office, covering biologics.

Company: OPKO Health, Inc.
Inspection date: March 1, 2021
Product type: biologics
Office: Florida District Office
People: Lawrence Reiter (company_representative)
Phillip Frost (company_representative)
Aleksandra Pastrak (company_representative)
Matthew F. Duff (investigator)
Allison Manners (company_representative)

ID · 0d69df08-b11b-4aab-b8f4-646e9ec24db9

Violation Codes1

21 CFR 312.57

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

EIR

OPKO Health, Inc.March 1, 2021